WHO prequalifies first generic Hepatitis C medicine & first HIV self-test
It means that the product can now be procured by the UN and financing agencies such as UNITAID, which now includes co-infection…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Hepatitis C
Browsing Tag
Hepatitis C
Prices of 103 formulation packs to come down after NPPA cap
The new prices will be effective from today, NPPA said in a notification on its website
Strides Shasun receives DCG(I) nod for Sofosbuvir
The product will be marketed under the brand name ‘Virso’ in India and overseas
Strides Shasun has received approval for…
Hetero bags DCG(I) approval for generic version of ‘Daclatasvir’
The product in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections
Hetero has…
NATCO launches hepatitis C drug in Nepal
The company has signed a non-exclusive licensing agreement with Gilead Sciences earlier in 2015
Natco Pharma has launched the…
Mylan launches Gilead Sciences’ Sovaldi tablets in India
Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease
Mylan launches generic Sofosbuvir tablets in India
The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease
DRL in partnership with Hetero
To accelerate access to treatment for Hepatitis C in India
Zydus with Gilead Sciences launches SoviHep
A novel oral treatment regimen for patients suffering from Hepatitis C